Trending Now
AC Immune SA (NASDAQ:ACIU) Reports Encouraging Results On the Study Of...
AC Immune SA (NASDAQ:ACIU) has released encouraging interim results from the on-going Phase 1b/2a clinical trial studying its first-in-class anti-phospho-Tau vaccine candidate ACY-35.030 in...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Altimmune Inc. (NASDAQ:ALT) Receives IND Approval From The FDA for Phase...
Altimmune Inc. (NASDAQ:ALT) announced that the FDA approved its IND application to carry out the second phase HepTcell study in chronic hepatitis B treatment.
Altimmune...
MAKE IT MODERN
LATEST REVIEWS
Impel NeuroPharma Inc. (NASDAQ: IMPL) Launches Trudhesa Nasal Spray For Prescription...
Impel NeuroPharma Inc. (NASDAQ: IMPL) has announced the availability of Trudhesa nasal spray for a prescription. The US FDA approved the 0.725mg per spray...
MAKE IT MODERN
PERFORMANCE TRAINING
Invesco QQQ Trust Series 1 (QQQ) surges giving bulls a psychological boost
The market was in risk off mode yesterday, but the buyers have stepped back in this morning in the QQQ’s. I don’t...
Salarius Pharmaceutical Inc. (NASDAQ:SLRX) Reports Q3 2020 Financial and Updates on Ewing Sarcoma Treatment
Salarius Pharmaceutical Inc. (NASDAQ:SLRX) has announced its financial results and corporate updates for the three months ended September 30, 2020.
Salarious expanded Ewing sarcoma clinical...
Why SGMD May be one of the Top Cannabis Growth Plays
One is wise to focus on one pivotal fact about a publicly traded almost more than any other: does it overpromise and underdeliver, or...
Palatin Technologies, Inc. (NYSEAMERICAN:PTN) Reveals Plans To Develop PL8177 As A Potential COVID-19 Treatment
Palatin Technologies, Inc. (NYSEAMERICAN:PTN) has announced plans to tap into PL8177's potential to combat some of the lung complications caused by COVID-19.
Researchers have discovered...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Expands Partnership On Development of TNX-1800 Release Preclinical Results...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has announced that it has expanded its strategic partnership with Southern Research. The Expansion includes T-cell immune response study...
MAKE IT MODERN
